Cargando…

Zonnic®: a new player in an old field

The tobacco industry is continually evolving to adapt to increasing tobacco control pressure and regulation, and to cater to consumer preferences. Recently, RJ Reynolds rolled-out a nicotine-containing gum, Zonnic®, which is marketed as a smoking cessation and reduction product and is sold at conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Min, Dunbar, Michael S., Setodji, Claude, Shadel, William G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585924/
https://www.ncbi.nlm.nih.gov/pubmed/28877727
http://dx.doi.org/10.1186/s13011-017-0124-3
_version_ 1783261717597257728
author Gong, Min
Dunbar, Michael S.
Setodji, Claude
Shadel, William G.
author_facet Gong, Min
Dunbar, Michael S.
Setodji, Claude
Shadel, William G.
author_sort Gong, Min
collection PubMed
description The tobacco industry is continually evolving to adapt to increasing tobacco control pressure and regulation, and to cater to consumer preferences. Recently, RJ Reynolds rolled-out a nicotine-containing gum, Zonnic®, which is marketed as a smoking cessation and reduction product and is sold at convenience stores at a lower price and in a smaller quantity than existing brands sold at pharmacies. The introduction of Zonnic® products is a critical first step in tobacco industry’s involvement in the NRT market and a serious indication of the evolving tobacco and nicotine-delivery industry and environment. It is likely that this trend will continue and spread, and as such, have a significant impact at multiple dimensions, including consumer perceptions and behavior, tobacco and NRT industry business strategy, and regulation and policy. In this special communication, we present an overview of the current marketing strategy for Zonnic®, discuss its potential impacts at the market level and at the level of the individual consumer, and suggest research and policy priorities based on the magnitude and urgency of the impacts.
format Online
Article
Text
id pubmed-5585924
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55859242017-09-06 Zonnic®: a new player in an old field Gong, Min Dunbar, Michael S. Setodji, Claude Shadel, William G. Subst Abuse Treat Prev Policy Review The tobacco industry is continually evolving to adapt to increasing tobacco control pressure and regulation, and to cater to consumer preferences. Recently, RJ Reynolds rolled-out a nicotine-containing gum, Zonnic®, which is marketed as a smoking cessation and reduction product and is sold at convenience stores at a lower price and in a smaller quantity than existing brands sold at pharmacies. The introduction of Zonnic® products is a critical first step in tobacco industry’s involvement in the NRT market and a serious indication of the evolving tobacco and nicotine-delivery industry and environment. It is likely that this trend will continue and spread, and as such, have a significant impact at multiple dimensions, including consumer perceptions and behavior, tobacco and NRT industry business strategy, and regulation and policy. In this special communication, we present an overview of the current marketing strategy for Zonnic®, discuss its potential impacts at the market level and at the level of the individual consumer, and suggest research and policy priorities based on the magnitude and urgency of the impacts. BioMed Central 2017-09-06 /pmc/articles/PMC5585924/ /pubmed/28877727 http://dx.doi.org/10.1186/s13011-017-0124-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Gong, Min
Dunbar, Michael S.
Setodji, Claude
Shadel, William G.
Zonnic®: a new player in an old field
title Zonnic®: a new player in an old field
title_full Zonnic®: a new player in an old field
title_fullStr Zonnic®: a new player in an old field
title_full_unstemmed Zonnic®: a new player in an old field
title_short Zonnic®: a new player in an old field
title_sort zonnic®: a new player in an old field
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585924/
https://www.ncbi.nlm.nih.gov/pubmed/28877727
http://dx.doi.org/10.1186/s13011-017-0124-3
work_keys_str_mv AT gongmin zonnicanewplayerinanoldfield
AT dunbarmichaels zonnicanewplayerinanoldfield
AT setodjiclaude zonnicanewplayerinanoldfield
AT shadelwilliamg zonnicanewplayerinanoldfield